ASCO GUIDELINES Bundle

Ovarian Masses and Treatment of Epithelial Ovarian Cancer

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475493

Contents of this Issue

Navigation

Page 9 of 37

10 Figure 2. Staging and Surgery Recommendations by Resource Level (cont'd) Basic Limited Enhanced Evaluated for surgical management taking into account tumor burden, functional status assessment (FSA), comorbidity Complete tumor cytoreduction to no gross residual disease/remove all macroscopic visible disease OR refer to higher- level cancer center Counsel patients on treatment options and refer them to a cancer treatment center with specialized surgical services Complete tumor cytoreduction to no gross residual disease/ remove all macroscopic visible disease If unable to travel to a distant health center, refer to palliative care recommendations If performed with currative intent, maximal effort cytoreductive surgery with the aim to remove all intra-abdominal macroscopic tumor Interval debulking is not recommended a NACT and interval debulking in FIGO stage IIIC or IV, in expectantly high morbidity surgery and patients with poor PS or unresectable disease NACT and interval debulking in International Federation of Gynecology and Obstetrics (FIGO) stage IIIC or IV, in expectantly high morbidity surgery and patients with poor performance status (PS) or unresectable disease OR refer to higher-level cancer center Basic setting recommendations Basic setting recommendation Surgery for Stage III/IV a Due to current gaps in health system and human resource availability. Staging and Surgery

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Ovarian Masses and Treatment of Epithelial Ovarian Cancer